Paper28871
Effects of aging and liver disease on disposition of lorazepam.
Kraus JW and 5 others. Clin Pharmacol Ther, 1978. Cited by 244 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Effects of aging and liver disease on disposition of lorazepam. Papers, record 28871. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28871
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Anti-Anxiety Agents | Major topic |
| Liver Diseases | Major topic |
| Lorazepam | Major topic |
| Acute Disease | |
| Adult | |
| Female | |
| Hepatitis, Viral, Human | |
| Humans | |
| Kinetics | |
| Liver Cirrhosis, Alcoholic | |
| Male | |
| Middle Aged |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 244 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37,328,712 | The Activity of Members of the UDP-Glucuronosyltransferase Subfamilies UGT1A and UGT2B is Impaired in Patients with Liver Cirrhosis. | Clin Pharmacokinet | 2023 | https://conductscience.org/library/papers/37328712 | PubMed |
| 37,039,129 | Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. | J Psychopharmacol | 2023 | https://conductscience.org/library/papers/37039129 | PubMed |
| 28,286,440 | Medical Care of the Patient With Compensated Cirrhosis. | Gastroenterol Hepatol (N Y) | 2006 | https://conductscience.org/library/papers/28286440 | PubMed |
| 27,606,309 | Sedation in Critically Ill Children with Respiratory Failure. | Front Pediatr | 2016 | https://conductscience.org/library/papers/27606309 | PubMed |
| 24,122,696 | Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment. | Clin Pharmacokinet | 2014 | https://conductscience.org/library/papers/24122696 | PubMed |
| 22,933,873 | Drug interactions: a primer for the gastroenterologist. | Gastroenterol Hepatol (N Y) | 2012 | https://conductscience.org/library/papers/22933873 | PubMed |
| 22,050,870 | Pharmacokinetics of intravenous lorazepam in pediatric patients with and without status epilepticus. | J Pediatr | 2012 | https://conductscience.org/library/papers/22050870 | PubMed |
| 21,671,987 | Adult age and ex vivo protein binding of lorazepam, oxazepam and temazepam in healthy subjects. | Br J Clin Pharmacol | 2011 | https://conductscience.org/library/papers/21671987 | PubMed |
| 19,530,743 | Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation. | Drug Saf | 2009 | https://conductscience.org/library/papers/19530743 | PubMed |
| 18,762,933 | Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. | Eur J Clin Pharmacol | 2008 | https://conductscience.org/library/papers/18762933 | PubMed |
| 18,399,712 | Free drug metabolic clearance in elderly people. | Clin Pharmacokinet | 2008 | https://conductscience.org/library/papers/18399712 | PubMed |
| 15,089,805 | Drug metabolism and ageing. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/15089805 | PubMed |
| 15,086,275 | Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. | Clin Pharmacokinet | 2004 | https://conductscience.org/library/papers/15086275 | PubMed |
| 14,748,812 | Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14748812 | PubMed |
| 14,678,335 | Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. | Br J Clin Pharmacol | 2004 | https://conductscience.org/library/papers/14678335 | PubMed |
| 10,451,781 | Pharmacokinetics of opioids in liver disease. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10451781 | PubMed |
| 10,427,466 | Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10427466 | PubMed |
| 10,408,740 | Managing alcohol withdrawal in the elderly. | Drugs Aging | 1999 | https://conductscience.org/library/papers/10408740 | PubMed |
| 9,784,934 | Pharmacokinetic alterations after severe head injury. Clinical relevance. | Clin Pharmacokinet | 1998 | https://conductscience.org/library/papers/9784934 | PubMed |
| 9,435,992 | Pharmacokinetics and pharmacodynamics of sedatives and analgesics in the treatment of agitated critically ill patients. | Clin Pharmacokinet | 1997 | https://conductscience.org/library/papers/9435992 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28871
GET https://conductscience.org/api/papers/v1/28871/cited_by?page=2